|Dr. Hans Arwidsson Ph.D.||CEO, Pres & Director||N/A||N/A||1958|
|Dr. Anna-Karin Maltais||Chief Scientific Officer, VP of R&D and Member of Scientific Advisory Board||N/A||N/A||N/A|
|Dr. Marie Olliver||Director of Clinical Devel.||N/A||N/A||N/A|
Eurocine Vaccines AB (publ) engages in the development of vaccines in Sweden. It has a research and collaboration agreement with Spixia Biotechnology AB to develop, manufacture, and commercialize chlamydia vaccine candidates. The company was incorporated in 1999 and is based in Solna, Sweden.
Eurocine Vaccines AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.